financetom
Business
financetom
/
Business
/
IndiGo introduces new flights on 4 UDAN routes. Here are the flight schedules and rates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IndiGo introduces new flights on 4 UDAN routes. Here are the flight schedules and rates
Apr 5, 2019 12:36 PM

India's largest airline, IndiGo on Friday announced six new flights, four of which will be operated under the UDAN scheme, effective from June 22, 2019.

These flights will be operated between the tier II cities of Kolkata, Allahabad, Raipur and Jabalpur, the airline said.

The routes under the Regional Connectivity Scheme, UDAN, include Kolkata-Allahabad, Allahabad-Kolkata, Raipur-Allahabad, Allahabad-Raipur flights, starting at Rs 1,999. The new routes will be serviced by turboprop ATR aircraft.

Here's the flight schedule:

First Published:Apr 5, 2019 9:36 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck secures $700 million funding from Blackstone to develop cancer therapy
Merck secures $700 million funding from Blackstone to develop cancer therapy
Nov 4, 2025
Nov 4 (Reuters) - Merck ( MRK ) said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 million to develop an experimental cancer therapy. Under the terms of the agreement, Blackstone will fund a portion of the development costs to test sac-TMT, an experimental antibody-drug conjugate. Antibody-drug conjugates are...
Rhythm Pharma Q3 product revenue up 54% yr/yr on IMCIVREE sales
Rhythm Pharma Q3 product revenue up 54% yr/yr on IMCIVREE sales
Nov 4, 2025
Overview * Rhythm Q3 2025 product revenue rises 54% yr/yr, driven by IMCIVREE sales * Net income for Q3 2025 misses analyst expectations, larger loss reported * FDA accepts sNDA for setmelanotide in acquired hypothalamic obesity, decision by Dec 20 Outlook * Company expects FDA decision on sNDA by December 20, 2025 * Rhythm anticipates Q4 2025 results from Phase...
Axcelis Q3 revenue beats estimates
Axcelis Q3 revenue beats estimates
Nov 4, 2025
Overview * Axcelis ( ACLS ) Q3 revenue of $213.6 mln beats analyst expectations * Adjusted EPS of $1.21 for Q3 exceeds consensus estimates * Company announces merger with Veeco Instruments to drive future growth Outlook * Axcelis expects Q4 2025 revenue of approximately $215 mln * Company projects Q4 2025 GAAP EPS of approximately $0.76 * Axcelis forecasts Q4...
Zoetis edges past Q3 revenue estimates, revises FY sales view
Zoetis edges past Q3 revenue estimates, revises FY sales view
Nov 4, 2025
Overview * Zoetis Q3 2025 revenue of $2.4 bln missed analyst expectations * Adjusted net income for Q3 2025 grows 9% organically * Company revises full year 2025 revenue guidance due to broader macro trends Outlook * Zoetis ( ZTS ) revises full-year 2025 revenue guidance to $9.400 bln - $9.475 bln * Company narrows full-year 2025 adjusted net income...
Copyright 2023-2026 - www.financetom.com All Rights Reserved